<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chatterjee A</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | Office of Extramural Research, National Institutes of Health (OER)</funding><funding>U.S. Department of Defense (United States Department of Defense)</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><pagination>9037</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11490551</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>The CUT and homeodomain are ubiquitous DNA binding elements often tandemly arranged in multiple transcription factor families. However, how the CUT and homeodomain work concertedly to bind DNA remains unknown. Using ONECUT2, a driver and therapeutic target of advanced prostate cancer, we show that while the CUT initiates DNA binding, the homeodomain thermodynamically stabilizes the ONECUT2-DNA complex through allosteric modulation of CUT. We identify an arginine pair in the ONECUT family homeodomain that can adapt to DNA sequence variations. Base interactions by this ONECUT family-specific arginine pair as well as the evolutionarily conserved residues are critical for optimal DNA binding and ONECUT2 transcriptional activity in a prostate cancer model. The evolutionarily conserved base inte</pubmed_abstract><journal>Nature communications</journal><pubmed_title>The homeodomain regulates stable DNA binding of prostate cancer target ONECUT2.</pubmed_title><pmcid>PMC11490551</pmcid><funding_grant_id>T32 CA240172</funding_grant_id><funding_grant_id>R01 CA220327</funding_grant_id><funding_grant_id>1R01CA220327</funding_grant_id><funding_grant_id>2P50CA092131</funding_grant_id><funding_grant_id>S10 OD016234</funding_grant_id><funding_grant_id>PC210486</funding_grant_id><funding_grant_id>P50 CA092131</funding_grant_id><pubmed_authors>Harter MR</pubmed_authors><pubmed_authors>Freeman MR</pubmed_authors><pubmed_authors>Murali R</pubmed_authors><pubmed_authors>Qian C</pubmed_authors><pubmed_authors>Katiki M</pubmed_authors><pubmed_authors>Komives EA</pubmed_authors><pubmed_authors>Chatterjee A</pubmed_authors><pubmed_authors>Silletti S</pubmed_authors><pubmed_authors>Gallent B</pubmed_authors></additional><is_claimable>false</is_claimable><name>The homeodomain regulates stable DNA binding of prostate cancer target ONECUT2.</name><description>The CUT and homeodomain are ubiquitous DNA binding elements often tandemly arranged in multiple transcription factor families. However, how the CUT and homeodomain work concertedly to bind DNA remains unknown. Using ONECUT2, a driver and therapeutic target of advanced prostate cancer, we show that while the CUT initiates DNA binding, the homeodomain thermodynamically stabilizes the ONECUT2-DNA complex through allosteric modulation of CUT. We identify an arginine pair in the ONECUT family homeodomain that can adapt to DNA sequence variations. Base interactions by this ONECUT family-specific arginine pair as well as the evolutionarily conserved residues are critical for optimal DNA binding and ONECUT2 transcriptional activity in a prostate cancer model. The evolutionarily conserved base inte</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-15T17:49:06.226Z</modification><creation>2025-04-04T02:57:28.49Z</creation></dates><accession>S-EPMC11490551</accession><cross_references><pubmed>39426953</pubmed><doi>10.1038/s41467-024-53159-8</doi></cross_references></HashMap>